PrimeRFP SCOUT · Federal Contract Recompete Brief

75F40124F19025Purpose of this no cost bilateral — Illumina, Inc

Illumina, Inc holds $100.9M across 1,348 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 5 related awards under parent 75F40123D00001. PoP ended Sep 30, 2026 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

Fda Office Of Acq Grant Svcs
Awarding office
Illumina, Inc
Recipient
Sep 30, 2026
PoP end
$6.4M
Obligated
$6.4M
Potential
325413
NAICS
6550
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal
Contract number75F40124F19025
Also listed as75F40123D00001-75F40124F19025
AgencyFda Office Of Acq Grant Svcs
Awarding officeFda Office Of Acq Grant Svcs
Awarding agencyDepartment of Health and Human Services (HHS)
Funding agencyDepartment of Health and Human Services (HHS)
IncumbentIllumina, Inc
CAGE1WCS2
UEIKMW3CRWNAAF3
NAICS325413

No full NAICS 325413 intel page yet. Browse NAICS intelligence

PSC6550
Parent IDIQ / IDV75F40123D00001
Place of performanceLAUREL MD
Pricing typeFirm Fixed Price
Extent competedNot Competed
PoP startNov 6, 2023
PoP end (current)Sep 30, 2026
Obligated$6.4M
Current value$6.4M
Potential value$6.4M

The Purpose of This No Cost Bilateral Modification Is to Extend the Line Items Period of PERFORMANCE. (NO COST MODS P00… is a federal award for Fda Office Of Acq Grant Svcs held by Illumina, Inc. Estimated value $6.4M ($6.4M obligated). Current period of performance ends Sep 30, 2026. Place of performance: LAUREL MD.

The purpose of this no cost bilateral modification is to extend the line items period of performance. (no cost mods p00006 and p00007 extended the pop, respectively, but did not extend the line items pop, not allowing vendor to submit invoice for wo. Latest action is a modification.

Recompete timing

Public
● Past PoP end (21 days ago)

Current PoP ended Sep 30, 2026 (21 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Want the durability read on 75F40124F19025? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Illumina, Inc — $100.9M obligated across 1,348 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($100.9M) · all agencies · Top 4 shown (94%); remaining ~6% is other agencies.
Department of Health and Human Services (HHS)$66.4M · 66%Department of Agriculture (USDA)$17.2M · 17%Department of Defense (DOD)$7.3M · 7%Department of Veterans Affairs (VA)$4.2M · 4%

Related awards

Same parent · incumbent
12639526F0821
THE PURPOSE OF THIS DELIVERY ORDER IS TO ENTER INTO A FIRM FIXED PRICE ORDER OFF USDA IDIQ…
$242K
Nov 9, 2026
1232SA26F0585
IDIQ 1232SA25D0004 SUPPLY ITEMS
$264K
Nov 13, 2026
36C25626P0992
PURCHASE AND INSTALLATION OF NEXTSEQ 2000 SEQUENCER
$311K
Dec 3, 2026
75N96022P00026
ISCAN SILVER SUPPORT PLAN
$182K
Dec 7, 2026
123A9426F0066
Q4 DELIVERY ORDER FOR WHOLE GENOME SEQUENCING KITS AND ASSOCIATED SUPPLIES WITH ILLUMINA I…
$429K
Dec 31, 2026

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Explore more pipelines →

Frequently asked questions

What is contract 75F40124F19025?

75F40124F19025 (Purpose of this no cost bilateral) is a Fda Office Of Acq Grant Svcs award with a potential value of $6.4M, currently held by Illumina, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75F40124F19025?

Fda Office Of Acq Grant Svcs awarded 75F40124F19025 to Illumina, Inc (potential $6.4M).

Who is the incumbent on 75F40124F19025?

Illumina, Inc is the incumbent with $100.9M across 1348 related awards in SCOUT’s public footprint. The current period of performance ends Sep 30, 2026.

When does Illumina, Inc’s 75F40124F19025 come up for recompete?

SCOUT tracks a period-of-performance end of Sep 30, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75F40124F19025? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Use SCOUT in your AI client — $29/mo

Classify + search inside Claude, ChatGPT, Cursor

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75F40124F19025